http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2664462-C9

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1aa877e508ad0f3a2ed38b5c6157f444
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
filingDate 2012-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bd15c9ebe33fd36ce00b088ff35d339
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eab1e4653052529a5d661b23a5b8c668
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed8889374da573cd75fd0144c60684f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0098e0aee77fb643ed4f2394bd1f266d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7eed0fb5fa5fb1424e8bcfcc24ef71a9
publicationDate 2018-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2664462-C9
titleOfInvention Combination Therapy with Anti-CD19 Antibody and Purine Analogue
abstract The invention relates to the field of biochemistry, in particular to the use of antibodies specific for CD19 and fludarabine for obtaining a synergistic combination for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and / or acute lymphoblastic leukemia. The invention effectively treats non-Hodgkin's lymphoma, chronic lymphocytic leukemia and / or acute lymphoblastic leukemia. 6 hp f-ly, 7 ill., 11 tablets., 3 ex.
priorityDate 2011-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-004107-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010272723-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011165152-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25660
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID378753
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4002
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453947315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503582
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TKU7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID28474
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID28912
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID238428
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20EU8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65628
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1KVQ9
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414861628
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22094277
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410862584
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500386
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582604
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06SH2
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID101886406
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457490455
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281050
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4002
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID390986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415956444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419564680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30751
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12478
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID940
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12487
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID378754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548745

Total number of triples: 64.